These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37919257)

  • 1. Drivers of disease severity and burden of hidradenitis suppurativa: a cross-sectional analysis on 553 German patients.
    Schultheis M; Grabbe S; Staubach P; Hennig K; Mauch M; Burckhardt M; Langer G; Heise M; Zamsheva M; Schollenberger L; Strobel A
    Int J Dermatol; 2024 Feb; 63(2):188-195. PubMed ID: 37919257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trial.
    Schultheis M; Staubach P; Nikolakis G; Schollenberger L; Mauch M; Burckhardt M; Heise M; Zamsheva M; Strobel A; Langer G; Bechara F; Kirschner U; Hennig K; Kunte C; Goebeler M; Grabbe S
    Br J Dermatol; 2023 Jul; 189(2):170-179. PubMed ID: 37132470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effectiveness.
    Heise M; Staubach P; Nikolakis G; Schollenberger L; Mauch M; Burckhardt M; Zamsheva M; Strobel A; Langer G; Bechara F; Kirschner U; Hennig K; Kunte C; Goebeler M; Podda M; Grabbe S; Schultheis M
    J Dermatolog Treat; 2023 Dec; 34(1):2284105. PubMed ID: 38010850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.
    Ingram JR; Bettoli V; Espy JI; Kokolakis G; Martorell A; Villani AP; Wallinger H; Coak E; Kasparek T; Muscianisi E; Richardson C; Kimball AB
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1597-1605. PubMed ID: 35445469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Hurley Stage III Hidradenitis Suppurativa Patients' Experiences With Pain: A Cross-Sectional Analysis.
    Johnston L; Dupuis E; Lam L; Poelman S
    J Cutan Med Surg; 2023; 27(5):487-492. PubMed ID: 37489915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
    Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
    Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
    Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
    Fabbrocini G; Ruina G; Giovanardi G; Dini V; Raone B; Venturini M; Caposiena Caro RD; Veraldi S; Cannavò SP; Merlo G; Bertoldi AM; Fiorentini F; Molinelli E; Atzori L; Bongiorno MR; Lo Re M; Skroza N; Lasagni C; Franchi C; Ardigò M; Di Costanzo L; Stingeni L; Amerio P; Sanna F; Pescitelli L; Broganelli P; De Cupis C; Gualberti G; Saragaglia V; Argenziano G
    Dermatology; 2022; 238(3):487-497. PubMed ID: 34474409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Internalized Skin Bias With Age, Adverse Psychopathology, and Health-Related Quality of Life Among Patients With Hidradenitis Suppurativa: A Cross-sectional Analysis.
    Butt M; Rigby A; Leslie DL; Foulke GT; Flamm A; Kirby JS; Chinchilli VM
    JAMA Dermatol; 2022 Apr; 158(4):432-438. PubMed ID: 35293961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidradenitis Suppurativa in Sweden: A Registry-Based Cross-Sectional Study of 13,538 Patients.
    Killasli H; Sartorius K; Emtestam L; Svensson Å
    Dermatology; 2020; 236(4):281-288. PubMed ID: 32015234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP).
    Delany E; Gormley G; Hughes R; McCarthy S; Kirthi S; Markham T; Tobin AM; Murphy M; Kirby B
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):467-473. PubMed ID: 29125658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
    Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
    Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease.
    Dufour DN; Emtestam L; Jemec GB
    Postgrad Med J; 2014 Apr; 90(1062):216-21; quiz 220. PubMed ID: 24567417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa.
    Morita A; Takahashi H; Ozawa K; Imafuku S; Nakama T; Takahashi K; Matsuyama T; Okubo Y; Kitamura S; Matsuda N; Zhao Y; Yokoyama M; Hayashi N; Terui T
    J Dermatol; 2019 Sep; 46(9):745-751. PubMed ID: 31282051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa [corrected].
    Patel ZS; Hoffman LK; Buse DC; Grinberg AS; Afifi L; Cohen SR; Lowes MA; Seng EK
    Curr Pain Headache Rep; 2017 Nov; 21(12):49. PubMed ID: 29094219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis suppurativa in the pediatric population.
    Liy-Wong C; Pope E; Lara-Corrales I
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study.
    Vossen ARJV; Schoenmakers A; van Straalen KR; Prens EP; van der Zee HH
    Am J Clin Dermatol; 2017 Oct; 18(5):687-695. PubMed ID: 28429245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.